Catalyst Wire Dossier Catalyst Wire Dossier

KB707

· Krystal Biotech, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KB707, covering 2025-05-18 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs [Phase 1, Phase 2]

See pricing